Monkeypox: The new plague?

I'm not a subscriber, but was able to view it. I at first watched the youtube version that has the covid/vax discussion censored although a transcript (composed of the less than accurate subtitles) is available.
Thanks Jeep I can now watch the utube version you posted here. Looking forward to it. I have no idea why it didnt show up on Tucker's site. x
I just went to the YouTube site and typed Tucker Carlson Neil Oliver into the search box and it comes right up and I'm not even signed in.

Reposting the youtube link again for anyone still experiencing no access:


I've noticed that some vids being posted to threads indicate "not available in your country". Don't know if this is part of the problem.
 
Bavarian to Reach Top End of Guidance After European Mpox Order
August 21, 2024 at 9:46 PM GMT+2
Bavarian Nordic A/S, the Danish supplier of a key vaccine against mpox, will attain the top end of its full-year guidance after firming up an order for the jabs from Europe.


The contract for 440,000 doses of the smallpox/mpox vaccine from an undisclosed European country will bring revenue to about 5.3 billion Danish kroner ($790 million) this year and generate 1.35 billion kroner in earnings before interest, tax, depreciation and amortization, the company said in a statement on Wednesday. The order was anticipated and won’t impact its remaining vaccine capacity for the year, the company said.

Bavarian’s mpox vaccine is the only inoculation for the deadly virus approved by both US and European Union regulators. It was developed after the 9/11 attacks when the US decided to stock up on vaccines for smallpox as part of its anti-terrorism program
Bavarian’s vaccine was approved for mpox in the US in 2019 and in Europe in 2022. The company now wants to extend formal approval to include adolescents and plans to study efficacy in kids.

Bavarian Nordic shares have climbed more than 30% since the start of the month. The company is scheduled to report results for the half-year on Thursday.

Description of Podcast
A mutated strain of Mpox in Central Africa has been declared a public health emergency of international by the World Health Organisation. About 15,000 cases have been reported so far in the DRC - but at least 6 other African countries have reported cases - and Burundi, Kenya, Rwanda and Uganda have reported their first ever Mpox cases.

Bloomberg Healthcare reporter Janice Kew joins Jennifer Zabasajja with the latest updates, and whether the international community is doing enough to support African countries in containing the outbreak

WIKI

MVA-BN

MVA-BN is a proprietary technology developed by Bavarian Nordic. It is derived from the Modified vaccinia Ankara virus. MVA-BN is characterized by the inability to replicate in human cells,[7] contrary to other vaccinia-based vaccines, which may replicate in humans, thus potentially causing severe and life-threatening side effects. Developed as the non-replicating smallpox and monkeypox vaccine, MVA-BN is approved in Canada as Imvamune,[8] in the European Union, as Imvanex,[9] and the United States asJynneos.[10][11][12] The vaccine was supplied for emergency use to the U.S. Strategic National Stockpile as well as other government stockpiles.

The vaccine is being deployed worldwide to combat the 2022 monkeypox outbreak, leading to concerns over vaccine nationalism and hoarding by countries with pre-existing contracts.[13]
 
The contract for 440,000 doses of the smallpox/mpox vaccine from an undisclosed European country will bring revenue to about 5.3 billion Danish kroner ($790 million) this year and generate 1.35 billion kroner in earnings before interest, tax, depreciation and amortization, the company said in a statement on Wednesday. The order was anticipated and won’t impact its remaining vaccine capacity for the year, the company said.

Bavarian’s mpox vaccine is the only inoculation for the deadly virus approved by both US and European Union regulators. It was developed after the 9/11 attacks when the US decided to stock up on vaccines for smallpox as part of its anti-terrorism program
Bavarian’s vaccine was approved for mpox in the US in 2019 and in Europe in 2022. The company now wants to extend formal approval to include adolescents and plans to study efficacy in kids.

Bavarian Nordic shares have climbed more than 30% since the start of the month. The company is scheduled to report results for the half-year on Thursday.

Well, we know how nefarious the PTB minions are and the above just confirms how devious and potentially deadly their nefarious plans are. They create the problem and then come up with deadly remedies being passed off as cures while also making a financial killing! Which is the biggest factor - attacking/killing the population or reaping massive wealth? I guess it's a twofer!

Meanwhile:

South African group refutes WHOs declaration of an mpox emergency and warns the public about the risks of the vaccines
The South Africa “Vaccine” Injury Medico-Legal Study Group (“SAVIMS”) has released a press statement to say that it does not support the Africa CDC and World Health Organisation declaration of a global health emergency for monkeypox, now known as mpox. Additionally, they have warned about the recommended live virus vaccines, Jynneos and ACAM2000: The vaccines are experimental use for monkeypox, as they were originally intended for smallpox; there are reported serious adverse effects; and, they contain live viral strains, which may potentially instigate a resurgence of the eradicated smallpox virus.

Aha! A possible resurgence of smallpox! Is this the real purpose and can we not think this is a long-wished for objective?!
“We warn members of the public about the inherent risks of taking any vaccine, including those proposed for mpox, of which the effectiveness and safety have not been reliably determined … There can be no justification for a vaccine with unknown adverse effects,” SAVIMS says.

Furthermore, SAVIMS emphasises the need for independent auditing of the collated monkeypox data in the Democratic Republic of Congo (“DRC”) and other African countries, as provided by the WHO, to ensure the accuracy and reliability of the statistics and analysis.


SAVIMS is a voluntary multidisciplinary association whose purpose is to follow the evidence, to gain and communicate knowledge about vaccine injuries. Its objectives are to promote human health and human rights as enshrined in the Bill of Rights of the Constitution of the Republic of South Africa. SAVIMS’ website is not yet live. Yesterday, James Roguski published the press statement below from SAVIMS.

Read the SAVIMS press statement at link:

From #4 of the SAVIMS press statement:
The article by Allan-Blitz et al, ‘A position statement on Mpox as a Sexually Transmitted Disease’, concluded that monkeypox is a sexually transmitted disease.

How is it then that children are being diagnosed with Mpox unless they are being sexually abused by infected adults? Is this the case?
 
So apparently it now can spread via other means aside from sexual transmission. How convenient.

The public should look out for early symptoms of having contracted the virus, which can be spread by skin-to-skin contact with an infected person or talking or breathing in close proximity to an infected person.

Bring out the muzzles!

The virus can also be spread by coming into contact with objects contaminated by the virus, such as bed linen, clothing, or towels, since the virus enters the body via broken skin, the respiratory tract, nose, mouth, and eyes.

Bali Tourists Must Complete New Mpox Screening Protocol On Arrival
 
So apparently it now can spread via other means aside from sexual transmission. How convenient.

I guess the next question is, is this true - has it been verified by reputable scientists? Was the virus gain-of-functioned into becoming more contagious - the answer to that must be yes if these new abilities are for real. Or are we being scammed again?
 
Well, according to statistics one in 3 children suffer at the hands of sexual
abusers.

  • The highest prevalence rate of child sexual abuse geographically was found in Africa (34.4%.) Europe showed the lowest prevalence rate (9.2%). America and Asia had prevalence rates between 10.1% and 23.9%.

That might explain why 70% of the cases there were children.
 
Back
Top Bottom